Literature DB >> 6699431

Genetic stability of A/Ann Arbor/6/60 cold-mutant (temperature-sensitive) live influenza virus genes: analysis by oligonucleotide mapping of recombinant vaccine strains before and after replication in volunteers.

N J Cox, A P Kendal.   

Abstract

Ten cold-adapted (ca) recombinant influenza viruses that had been derived by reassortment between the ca temperature-sensitive (ts) A/Ann Arbor/6/60 mutant and selected wild-type viruses were examined by RNA oligonucleotide mapping for the presence or absence of several previously identified oligonucleotide markers. These markers comprise oligonucleotides that appeared only in the mutant donor strain after cold adaptation and other oligonucleotides present only in the parent A/Ann Arbor/6/60 wild-type virus. The markers in the mutant donor strain were transferred without change to the recombinant ca vaccine strains, and reversion causing a reappearance of markers for the wild-type A/Ann Arbor/6/60 virus did not occur. Furthermore, examination by oligonucleotide mapping of 10 isolates from vaccinated, seronegative children revealed a high degree of genetic stability of the viral genome; an oligonucleotide change was detected in only one of the 10 isolates examined.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6699431     DOI: 10.1093/infdis/149.2.194

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  A practical approach to genetic screening for influenza virus variants.

Authors:  S Zou
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

2.  Biological characteristics of a cold-adapted influenza A virus mutation residing on a polymerase gene.

Authors:  T Odagiri; A Tosaka; N Ishida; H F Maassab
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

3.  Immunity to influenza A H9N2 viruses induced by infection and vaccination.

Authors:  X Lu; M Renshaw; T M Tumpey; G D Kelly; J Hu-Primmer; J M Katz
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans.

Authors:  X Lu; T M Tumpey; T Morken; S R Zaki; N J Cox; J M Katz
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

5.  Antigenic and genetic variation in influenza A (H1N1) virus isolates recovered from a persistently infected immunodeficient child.

Authors:  E Rocha; N J Cox; R A Black; M W Harmon; C J Harrison; A P Kendal
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

6.  Diagnostic approach for differentiating infected from vaccinated poultry on the basis of antibodies to NS1, the nonstructural protein of influenza A virus.

Authors:  Terrence M Tumpey; Rene Alvarez; David E Swayne; David L Suarez
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

7.  Laboratory characterization of a swine influenza virus isolated from a fatal case of human influenza.

Authors:  P A Rota; E P Rocha; M W Harmon; V S Hinshaw; M G Sheerar; Y Kawaoka; N J Cox; T F Smith
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

8.  Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus.

Authors:  Terrence M Tumpey; Adolfo García-Sastre; Jeffery K Taubenberger; Peter Palese; David E Swayne; Christopher F Basler
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-12       Impact factor: 11.205

9.  Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection.

Authors:  T M Tumpey; M Renshaw; J D Clements; J M Katz
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

10.  A Mutated PB1 Residue 319 Synergizes with the PB2 N265S Mutation of the Live Attenuated Influenza Vaccine to Convey Temperature Sensitivity.

Authors:  Andrew Cox; Jordana Schmierer; Josephine D'Angelo; Andrew Smith; Dustyn Levenson; John Treanor; Baek Kim; Stephen Dewhurst
Journal:  Viruses       Date:  2020-10-31       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.